Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial.
Saved in:
| Title: | Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial. |
|---|---|
| Authors: | Landier W; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: wclandier@uabmc.edu., Bhatia S; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Wong FL; Department of Population Sciences, City of Hope, Duarte, CA, USA., York JM; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Flynn JS; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA., Henneberg HM; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Singh P; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Adams K; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Wasilewski-Masker K; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA., Cherven B; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA., Jasty-Rao R; Division of Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA., Leonard M; Division of Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA., Connelly JA; Department of Pediatrics, Vanderbilt University, Nashville, TN, USA., Armenian SH; Department of Population Sciences, City of Hope, Duarte, CA, USA., Robison LL; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA., Giuliano AR; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, FL, USA., Hudson MM; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA., Klosky JL; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA. |
| Source: | The Lancet. Child & adolescent health [Lancet Child Adolesc Health] 2022 Jan; Vol. 6 (1), pp. 38-48. Date of Electronic Publication: 2021 Nov 10. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Equivalence Trial |
| Journal Info: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101712925 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-4650 (Electronic) Linking ISSN: 23524642 NLM ISO Abbreviation: Lancet Child Adolesc Health Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
